Executive Medical Director, Global Medical Affairs, Neuroscience

Major Accountabilities:

• Lead development and execute medical affairs strategy for priority programs including transformative tactics such as: research/population health, innovative partnerships and integrated evidence plans
• Co-develop plans for evidence generation, medical launch plans, MSL / Field Medical Affairs strategy, medical education programs, scientific publication planning and Medical Expert network development with TAs
• Co-own the development and implementation of innovative education and scientific communication plans for external stakeholders.
• Financial tracking to ensure timely and cost-effective development & execution of medical activities.
• Partner with Development, S&G, US and International cross-functions to shape portfolio early and diversify evidence to achieve broad access at launch and to enhance impact on clinical practice for priority programs.
• Represent GMA around prioritized portfolio with internal and external audiences, in collaboration with TAs including the investment, medical and regulatory communities, as well as pharmaceutical or biotechnology industry collaborators/partners.
• Represent “the voice of the patient” internally and evaluate factors relevant to a patient’s informed decision making.
• Provide proactive input to Development on potential new therapeutic indications, to enrich Registration Programs and to consider new therapeutic opportunities.
• Ensure that Patient Access programs are supported for all brands within the GMA and delivered with full compliance.
• Ensures GMA activities are designed and executed in compliance with company policy guidelines and highest medical quality standards.
• Provide proactive medical input to asset lifecycle management to consider new therapeutic opportunities.

Must have:

• MD, Neurologist (Preferred) or PhD/PharmD in Neuroscience/ Health Sciences. Specialist Degree or specialist qualification in Gene therapy related to discipline for which is responsible is an advantage
• 6+ years in Pharmaceutical Industry experience in Medical Affairs and/or Clinical Development
• Critical thinker and with ability to navigate uncertainty without major supervision.
• Fluent oral and written English; Other relevant languages are an advantage
• Strategic mindset and able to establish credibility and influence across a range of diverse stakeholders in a matrix organization to drive change.
• Ability to truly collaborate across functions and markets: serve-partner-co-create.
• Able to navigate in an environment of shared outcomes and cross-business accountabilities.
• Deep understanding of health care systems and key external stakeholders
• Strong track record of delivery focus for time and quality in medical affairs projects
• Successful development and implementation of innovative programs and processes
• Understands unmet medical needs, generates the right evidence to fulfil them, uses innovative, multichannel communication formats for effective evidence dissemination.
• Credibility as peer expert with external stakeholders
• Agile mindset & ability to lead in an agile organization across Disease Areas
• Firm working knowledge of GCP, scientific and clinical methodology, protocol designs, management and regulatory requirements for clinical studies designated for review by regulatory authorities.

Preferred

• Highly preferred: Neuromuscular, Rare Disease, siRNA, Gene Therapy, medical affairs early asset lifecycle, pre-launch and launch experience in Global organizations
• Experience in developing and executing “Best in Class” processes at scale
• Clinical trial research experience conducted in a pharmaceutical or equivalent academic environment in TA of interest is strongly desired

Commitment to Diversity & Inclusion:

Novartis is committed to building an outstanding, inclusive work environment and diverse teams’ representative of the patients and communities we serve.